In addition, we performed a survival analysis of the genetic alteration status of NFE2L3 was performed on the entire TCGA pan-cancer cohort, however the results revealed no significant correlation between the genetic alteration status of NFE2L3 and patient prognosis. The gene discussed is NFE2L3; the disease is cancer.